Status:
COMPLETED
Analysis of the Diagnostic Performance of LacryDiag, a New Analyzer of the Ocular Surface in the Dry Eye
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Dry Eye
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
LacryDiag is a new Conformity European (CE) marked diagnostic imaging device devoted to the analysis of the ocular surface. It is an "all in one" device that provides 4 data: non-invasive break-up tim...
Detailed Description
The primary purpose of this study is to compare the value of Break-Up-Time (BUT) between Non-Invasive Break-Up-Time (NIBUT) measured by LacryDiag and Standard Break-Up-Time (SBUT) measured by usual pr...
Eligibility Criteria
Inclusion
- Affiliates or beneficiaries of social security scheme
- With Dry eye of any cause, diagnosed with conventional means
- Signed informed consent
Exclusion
- Major blepharospasm
- Serious illness preventing participation according to investigator
- Allergy to fluorescein
- Pregnant or / and breastfeeding women
- Under guardianship, curatorship or safeguard of justice
- Unable to express their consent
- Person in emergency situation
Key Trial Info
Start Date :
November 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 27 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04093037
Start Date
November 14 2019
End Date
August 27 2020
Last Update
September 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Saint-Etienne
Saint-Etienne, France